Managing Your Idiopathic Pulmonary Fibrosis Findings of a systematic review highlight the need for standardized assessment tools and targeted treatments for chronic cough in patients with idiopathic pulmonary fibrosis and other interstitial Boehringer Ingelheim said that it will submit a new drug application for nerandomilast based on the positive results
Managing Diagnostic Procedures In Idiopathic Pulmonary Fibrosis The FDA’s clearance could double Kisqali’s breast cancer market Elsewhere, Novo is exploring new ways to deliver genetic therapies and Bain is funding a growing CDMO Dr Frohna discusses some therapies under investigation for idiopathic and progressive pulmonary fibrosis, including one targeting the PDE4 pathway Product sales in the first half of the year amounted to CHF 175m and services revenues to CHF023m, whereby Curatis AG, which was acquired on 26 April 2024, is only included in this figure for 2
Comments are closed.